P105 Treatment options in patients with metastatic castrate-resistant prostate cancer (mCRPC) previously treated with a docetaxel-containing regimen: A single UK cancer centre's experience using patients within the early access programme and cancer drugs fund

✍ Scribed by Hague, C.J.; Kelly, C.L.S.; Cornthwaite, S.A.; Birtle, A.J.

• Book ID: 122285018
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 65 KB
• Volume: 12
• Category: Article
• ISSN: 1569-9056
• DOI: 10.1016/S1569-9056(13)62430-6